The invention relates to sulfated oligosaccharides, more particularly to new pharmaceutical uses of sulfated oligosaccharides. The invention provides a method of preventing, treating or alleviating the symptoms of acute and chronic', inflammatory disorders of the airways of mammals - including asthma and asthma-related pathologies. The invention further provides use of a sulfated oligosaccharide in the preparation of a medicament for the treatment of acute and chronic inflammatory disorders of the airways of mammals. The invention yet further provides use of a sulfated oligosaccharide to preventing, treating or alleviating the symptoms of acute and chronic inflammatory disorders of the airways of mammals - including asthma and asthma-related pathologies.
申请公布号
WO2006017752(A8)
申请公布日期
2007.03.08
申请号
WO2005US27921
申请日期
2005.08.05
申请人
IVAX CORPORATION;IVAX DRUG RESEARCH INSTITUTE, LTD.;KUSZMANN, JANOS;KURUCZ, ISTVAN;MEDGYES, GABOR;BODOR, NICHOLAS
发明人
KUSZMANN, JANOS;KURUCZ, ISTVAN;MEDGYES, GABOR;BODOR, NICHOLAS